INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY

NEW YORK, November 11, 2025 (ACCESSWIRE) Pomerantz LLP is investigating claims on behalf of investors of  Surgery Partners, Inc. (“Surgery Partners” or the “Company”) (NASDAQ: SGRY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Surgery Partners and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On November 10, 2025, Surgery Partners issued a press release announcing its financial results for the third quarter of 2025 and held an earnings call to discuss the same.  The Company lowered its full-year revenue guidance to a range of $3.275 billion to $3.3 billion, and its adjusted EBITDA guidance to a range of $535 million to $540 million.  Surgery Partners’ management attributed the guidance revision to timing delays in capital deployment, lost earnings from ambulatory surgical center divestitures, and a cautious stance on commercial payer mix and volume in the fourth quarter. 

On this news, Surgery Partners’ stock price fell $5.47 per share, or 25.42%, to close at $16.04 per share on November 10, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.